| scholarly article | Q13442814 |
| P50 | author | Ian Young | Q43287105 |
| P2093 | author name string | Michael J Moore | |
| Jane McEneny | |||
| Jennifer A Adgey | |||
| Colum G Owens | |||
| Bernie Smith | |||
| Conor J McCann | |||
| Peter C Sharpe | |||
| Ian B A Menown | |||
| Ben M Glover | |||
| P2860 | cites work | Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction | Q22242900 |
| The sensitivity of cardiac markers: an evidence-based approach | Q33869012 | ||
| Do we need additional markers of myocyte necrosis: the potential value of heart fatty-acid-binding protein. | Q34306830 | ||
| Fatty acid-binding proteins as plasma markers of tissue injury | Q34384710 | ||
| D-Dimer is an early diagnostic marker of coronary ischemia in patients with chest pain | Q39545708 | ||
| Human heart-type fatty-acid-binding protein as a point-of-care test in the early diagnosis of acute myocardial infarction | Q57909840 | ||
| P433 | issue | 23 | |
| P921 | main subject | myocardial infarction | Q12152 |
| biomarker | Q864574 | ||
| acute myocardial infarction | Q18558122 | ||
| P304 | page(s) | 2843-2850 | |
| P577 | publication date | 2008-08-05 | |
| P1433 | published in | European Heart Journal | Q2286839 |
| P1476 | title | Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T | |
| P478 | volume | 29 |
| Q36541913 | A Study on the Role of Heart Type Fatty Acid Binding Protein in the Diagnosis of Acute Myocardial Infarction |
| Q92619325 | A faster detection method for high-sensitivity cardiac troponin-POCT quantum dot fluorescence immunoassay |
| Q38751990 | A synergistic role of ischemia modified albumin and high-sensitivity troponin T in the early diagnosis of acute coronary syndrome |
| Q37765287 | A timely diagnosis of myocardial infarction. |
| Q35771734 | An evidence-based approach to the assessment of heart-type Fatty Acid binding protein in acute coronary syndrome. |
| Q34561285 | Assessment of acute myocardial infarction: current status and recommendations from the North American society for Cardiovascular Imaging and the European Society of Cardiac Radiology |
| Q47139124 | Biomarkers identification for acute myocardial infarction detection via weighted gene co-expression network analysis |
| Q36129159 | Chemiluminometric Immunosensor for High-Sensitivity Cardiac Troponin I Employing a Polymerized Enzyme Conjugate as a Tracer |
| Q64226682 | Circulating MiR-17-5p, MiR-126-5p and MiR-145-3p Are Novel Biomarkers for Diagnosis of Acute Myocardial Infarction |
| Q64054772 | Circulating miR-26a-1, miR-146a and miR-199a-1 are potential candidate biomarkers for acute myocardial infarction |
| Q46188463 | Clinical and analytical evaluation of an immunoturbidimetric heart-type fatty acid-binding protein assay |
| Q37765289 | Clinical application of sensitive cardiac troponin assays: potential and limitations |
| Q36202928 | Clinical utility of diagnostic guidelines and putative biomarkers in lymphangioleiomyomatosis. |
| Q42200250 | Comparative study of high sensitivity troponin T and heart-type fatty acid-binding protein in STEMI patients |
| Q44325501 | Comparison of contemporary troponin assays with the novel biomarkers, heart fatty acid binding protein and copeptin, for the early confirmation or exclusion of myocardial infarction in patients presenting to the emergency department with chest pain |
| Q64071305 | Development of a Quantitative Detection Card for Heart-type Fatty Acid-binding Protein based on Background Fluorescence Quenching Immune Chromatography |
| Q35623487 | Diagnosis of Non-ST-Elevation Acute Coronary Syndrome by the Measurement of Heart-Type Fatty Acid Binding Protein in Serum: A Prospective Case Control Study |
| Q33773201 | Diagnostic accuracy of heart fatty acid binding protein (H-FABP) and glycogen phosphorylase isoenzyme BB (GPBB) in diagnosis of acute myocardial infarction in patients with acute coronary syndrome |
| Q33959560 | Diagnostic evaluation of the MRP-8/14 for the emergency assessment of chest pain |
| Q35085516 | Diagnostic performance of high-sensitivity troponin T, myeloperoxidase, and pregnancy-associated plasma protein A assays for triage of patients with acute myocardial infarction |
| Q85040114 | Diagnostic value of MPO plasma levels in patients admitted for suspected myocardial infarction |
| Q53081382 | Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. |
| Q50536931 | Early diagnosis of postpartum acute myocardial infarction with combined use of troponin T and heart-type fatty acid-binding protein rapid assay. |
| Q37564704 | Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC). |
| Q51837358 | Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study. |
| Q88912552 | Genes associated with inflammation and the cell cycle may serve as biomarkers for the diagnosis and prognosis of acute myocardial infarction in a Chinese population |
| Q34330829 | Glycogen phosphorylase isoenzyme BB in the diagnosis of acute myocardial infarction: a meta-analysis |
| Q54978892 | Heart-type fatty acid binding protein (H-FABP) as a biomarker for acute myocardial injury and long-term post-ischemic prognosis. |
| Q47639184 | Heart-type fatty acid-binding protein (H-FABP) and highly sensitive troponin T (hsTnT) as markers of myocardial injury and cardiovascular events in elective percutaneous coronary intervention (PCI). |
| Q36426643 | Heart-type fatty acid-binding protein (H-FABP) as an early diagnostic biomarker in patients with acute chest pain |
| Q42369140 | Heart-type fatty acid-binding protein as a predictor of cardiac ischemia in intractable seizures in children |
| Q33786119 | High-sensitive troponin T assay for the diagnosis of acute myocardial infarction: an economic evaluation |
| Q37977873 | High-sensitive troponin T measurements: what do we gain and what are the challenges? |
| Q55304633 | High-sensitivity troponin T and copeptin in non-ST acute coronary syndromes: implications for prognosis and role of hsTnT and copeptin in non-STEACS. |
| Q44781657 | Identifying key genes associated with acute myocardial infarction |
| Q45743912 | Impact of copeptin on diagnosis, risk stratification, and intermediate-term prognosis of acute coronary syndromes |
| Q54628037 | Impact of soluble fms-like tyrosine kinase-1 and placental growth factor serum levels for risk stratification and early diagnosis in patients with suspected acute myocardial infarction. |
| Q36931261 | Increase in cardiac myosin binding protein-C plasma levels is a sensitive and cardiac-specific biomarker of myocardial infarction |
| Q37091869 | Knockdown of FABP3 impairs cardiac development in Zebrafish through the retinoic acid signaling pathway |
| Q90153373 | Label-Free, Highly Sensitive Electrochemical Aptasensors Using Polymer-Modified Reduced Graphene Oxide for Cardiac Biomarker Detection |
| Q38809666 | MicroRNAs as circulating biomarkers in acute coronary syndromes: A review |
| Q36016656 | Perioperative heart-type fatty acid binding protein is associated with acute kidney injury after cardiac surgery |
| Q48488258 | Predictive value of the heart-type fatty acid-binding protein and the Pulmonary Embolism Severity Index in patients with acute pulmonary embolism in the emergency department |
| Q42804325 | Pregnancy-associated plasma protein A (PAPP-A) for the early diagnosis of myocardial infarction: more doubts than certainties |
| Q38262572 | Pregnancy-associated plasma protein-A and the vulnerable plaque. |
| Q37798014 | Proteomic biomarkers for diagnosis in acute myocardial infarction. |
| Q38201763 | Role of MIF in myocardial ischaemia and infarction: insight from recent clinical and experimental findings |
| Q46611452 | Serum Level of Heart-Type Fatty Acid Binding Protein (H-FABP) Before and After Treatment of Congestive Heart Failure in Children |
| Q83974155 | Silencing of FABP3 promotes apoptosis and induces mitochondrion impairment in embryonic carcinoma cells |
| Q37225099 | Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers |
| Q53306185 | Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine. |
| Q51535970 | The role of serum levels of microRNA-21 and matrix metalloproteinase-9 in patients with acute coronary syndrome. |
| Q39268332 | Using expert elicitation to estimate the potential impact of improved diagnostic performance of laboratory tests: a case study on rapid discharge of suspected non-ST elevation myocardial infarction patients. |
| Q98164794 | Using the SYNTAX score to predict myocardial injury early after on-pump coronary artery bypass surgery: a single-centre experience analysis |
Search more.